NKGen Biotech Inc (PK) (NKGN) Quote

https://securityboulevard.com/2025/06/securing-ach-against-emerging-authentication-bypass-methods/
ACT NOW WITH WAVE.

True. Although I would think that Thiago got blindsided by the lawsuit against HMBL et al. Those legal bills are going to eat into that $ 30k per day.

$AMOD - Alpha Modus Expands CashX Rollout via Strategic U.S. Reseller Agreement with Genmega
https://finance.yahoo.com/news/alpha-modus-expands-cashx-rollout-120000815.html

Lovin' those call options.....!

Final Data from Teva’s PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® (fremanezumab) for the Prevention of Chronic and Episodic Migraine

https://finance.yahoo.com/news/final-data-teva-pearl-real-070000414.html

Final analysis of PEARL real wo

Good morning gail. Nice pre market start 😃

$OP

The patent for Eliquis (apixaban) is set to expire on 11/21/26 . This means that generic versions of the drug may become available after this date.  

The main Xarelto (rivaroxaban) patent, including pediatric exclusivity, is scheduled to expire in May 2025. Specifically, one patent ex

TSNP, not TNSP

Androxgh0st Continues Exploitation: Operators Compromise a US University For Hosting C2 Logger

~ by Koushik Pal, June 22, 2025

CloudSEK uncovered that the Androxgh0st botnet compromised a University of California, San Diego subdomain to host its C2 logger. Active since

https://www.saba.ye/en/news3504450.htm
ACT NOW WITH WAVE.

Steve, I noticed the RSI and Stoch on the daily is close to the top. What do you make of that. The last several times in that zone resulted in major downwaves. I'm guessing price could continue climbing toward 10, and the rsi would just float into that zone, but at some point, it's going to have

Of course! Sorry but I was reading the text without taking time to analyze it thoroughly. Wave should be used quickly and make passwords irrelevant.

He's not under a deadline like Oscar is. That's your A-typical VC Insider buy right there. The timing is a dead giveaway, VC's often cram there pockets first, so other insiders can then ioad up.

The Cochran county appraisal district has put a value of $407,418 on the 6780.250 acre dean unit of vision. This is a few hundred million less than Joshy. Lol. Plus, the have not paid their $12,297.53 due on taxes. Lol. This is getting hilarious. They are another $1,601.29 on the Masten

Good morning CLNVERS 

$ECGI https://www.otcmarkets.com/stock/ECGI/security

$ECGI https://www.otcmarkets.com/stock/ECGI/security

The patent for Eliquis (apixaban) is set to expire on . This means that generic versions of the drug may become available after this date. 

The main Xarelto (rivaroxaban) patent, including pediatric exclusivity, is scheduled to expire in . Specifically, one patent expired on February

It's a classic, Morning.

Bruh, have a cold coopers pale ale and relax 
Don't let this stonk ruin your emotions 

It’s crucial for Andy to support the share price in the coming days, ahead of the shareholders' meeting.

Another Monday with this ticker doing nothing, but the pumpers are saying it's all good.
The great CEO is a financial genius. Everything points positive.
Things are lining up...
All based on nothing but the hairs on their backs standing on end.
Wake up call...this ticke

Do you expect we can
Get there 10$PPS organicly based on news , photos, big names , amount of prod. silk and with no RS?
Is this why 10$PPS for a buyout is too low for you ? Many Thanks ?

I hope you a right , but then the value of a company with 1B share will be huge imo

Oxford City Council suffers breach exposing two decades of data

~ by Bill Toulas, June 22, 2025

Oxford City Council warns it suffered a data breach where attackers accessed personally identifiable information from legacy systems.

The incident has also cau

$RITE Waiver Letter Request is Approved by SEC Staff

https://mineral-rite.com/investor-relations/

This waiver was requested in response to SEC Staff comments on the Company's recently filed Form 10, as amended.

A copy of the SEC’s waiver letter is attache